Structural brain volume differences between cognitively intact ApoE4 carriers and non-carriers across the lifespanRyan J.Piers1309-1312
Roles of Eph/ephrin bidirectional signaling during injury and recovery of the central nervous systemYue Wan, Jin-Shan Yang, Li-Cai Xu, Xiao-Jiang Huang, Wei Wang, Min-Jie Xie1313-1321
Neuroplasticity, limbic neuroblastosis and neuro-regenerative disordersMahesh Kandasamy, Ludwig Aigner1322-1326
A tissue-engineered rostral migratory stream for directed neuronal replacementJohn C.O'Donnell, Kritika S.Katiyar, Kate V.Panzer, D.Kacy Cullen1327-1331
Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects:implications for Parkinson's diseaseEoin O'Neill, Andrew Harkin1332-1337
Targeting the mitochondrial permeability transition pore in traumatic central nervous system injuryJoe E.Springer, Pareshkumar Prajapati, Patrick G.Sullivan1338-1341
Current surgical treatments for Parkinson's disease and potential therapeutic targetsDarrin J.Lee, Robert F.Dallapiazza, Philippe De Vloo, Andres M.Lozano1342-1345
Amnion epithelial cells-a novel therapy for ischemic stroke?Megan A.Evans, Brad R.S.Broughton, Grant R.Drummond, Henry Ma, Thanh G.Phan, Euan M.Wallace, Rebecca Lim, Christopher G.Sobey1346-1349
Cell-based therapies for neural replacement strategies in stroke-related neurodegeneration:neurophysiological insights into stem progenitor cell neurogenesis within a host environmentOlga Kopach, Tatyana Pivneva1350-1351
